Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label doxil. Show all posts
Showing posts with label doxil. Show all posts
Wednesday, March 21, 2012

abstract: Does long-term treatment with Doxil(®) predispose patients to oral cancer?

›
Does long-term treatment with Doxil(®) predispose patients to oral cancer? Abstract We present a possible adverse reaction related t...
Thursday, March 15, 2012

Endocyte jumps on plans for cancer drug candidate - Bioscience Technology (EC145 vs Doxil - re: Doxil drug shortage....)

›
Endocyte jumps on plans for cancer drug candidate - Bioscience Technology : The Inquisitr Endocyte jumps on plans for cancer drug can...
Monday, February 20, 2012

New source found for cancer drug Doxil, in short supply - USATODAY.com - Lipodox

›
"Patients with ovarian cancer and other deadly tumors will regain access to an important chemotherapy drug, Food and Drug Administra...
Wednesday, February 01, 2012

abstract: Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial

›
Background: In the CALYPSO trial, carboplatin–pegylated liposomal doxorubicin (CD) demonstrated superior therapeutic index versus carbopl...
Wednesday, January 25, 2012

Johnson & Johnson Profit Slumps 89% on Charges - WSJ.com (references to Doxil/drug shortages)

›
"Mr. Weldon said J&J learned a "painful lesson" from the ongoing supply shortage for its drug Doxil, which treats ovaria...
Wednesday, January 11, 2012

Patients left in lurch by cancer drug shortage - ABC Online

›
Patients left in lurch by cancer drug shortage ABC Online Hospitals are running short of an important drug used to treat several form...
Thursday, July 28, 2011

abstract: Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer.

›
Markman M. Source Cancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia, PA, USA. Abstract Pegylated li...
Sunday, June 12, 2011

Long-Term Doxorubicin Linked to Secondary Oral Cancers

›
"....... Four patients who received long-term PLD for advanced-stage ovarian cancer developed malignant and/or premalignant lesions o...
Sunday, April 24, 2011

full free access: Docetaxel Distribution Following Intraperitoneal Administration in Mice Journal of Pharmacy & Pharmaceutical Sciences (technical)

›
Note : in mice (research); technical
Wednesday, September 29, 2010

free full access: Sept 2010 Pegylated liposomal doxorubicin in the management of ovarian cancer

›
"This review aims at summarizing the available evidence and the new perspectives for the clinical role of PLD in the management of pa...
Monday, September 06, 2010

abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?

›
"PLD is cardiac safe for long-term treatment of metastatic solid tumors. Its maximal cumulative dose remains undefined . "
Tuesday, July 20, 2010

Trabectedin (Yondelis) plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval (full access)

›
Friday, July 16, 2010

A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gyne

›
Blogger's Note: in the absence of full access to the article, this conclusion 'needs more research' "CONCLUSIONS :: Pyrid...
Saturday, February 06, 2010

Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial

›
Conclusion The combination of PLD and continuous IFO is a feasible and efficient treatment in patients with relapsed ovarian cancer, esp...